Olivier is Associate Professor of Health Economics at the Department of Public Health Sciences, Faculty of Medicine, University of Liège in Belgium. He is also an invited lecturer at the Department of Pharmacy and the Department of Biomedical Sciences, Faculty of Medicine, University of Namur in Belgium. He lectures in health economics (theory & applied modeling), decision sciences and pharmacoepidemiology. Olivier holds a PhD in Public Health Sciences from the University de Liège and an MSc in Mathematical Economics from the University of Paris I – Panthéon Sorbonne. His research interests include financial modeling of patients and market access strategies and population-based modeling. Olivier has nearly 20 years of experience as an economic and financial modeler gained in the private sector at IMS Health (now IQVIA), Bristol-Myers & Squibb and GlaxoSmithKline Vaccines. Olivier has designed numerous economic and financial models across a broad spectrum of disease areas and his experience spans all types of healthcare technologies including drugs, biologics, vaccines, devices, and diagnostics.